EP 2480249 B1 20150128 - Plasmin for the treatment of filtration failure after trabeculectomy
Title (en)
Plasmin for the treatment of filtration failure after trabeculectomy
Title (de)
Plasmin zur Behandlung von Filtrationsfehlern nach Trabeculektomie
Title (fr)
Plasmine pour le traitement de defauts de filtration suite à la trabéculectomie
Publication
Application
Priority
- US 23772309 P 20090828
- EP 09168912 A 20090828
- EP 2010062584 W 20100827
- EP 10751599 A 20100827
Abstract (en)
[origin: WO2011023805A1] The current invention relates to the improvement of trabeculectomy surgery. The improvement more specifically resides in an extended lifetime of the sclera-corneal drainage channel created by trabeculectomy surgery. The improvement is obtained by post-surgical administration of a plasmin or active derivative thereof in the form of topical eye drops alone, by anterior chamber injection alone, or by any combination of these.
IPC 8 full level
A61K 38/48 (2006.01); A61K 9/00 (2006.01); A61K 47/12 (2006.01); A61P 27/02 (2006.01)
CPC (source: EP US)
A61K 9/0048 (2013.01 - EP US); A61K 9/0051 (2013.01 - EP US); A61K 38/484 (2013.01 - EP US); A61K 45/06 (2013.01 - US); A61K 47/12 (2013.01 - EP US); A61P 23/02 (2017.12 - EP); A61P 27/02 (2017.12 - EP); A61P 27/08 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 31/12 (2017.12 - EP)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR
Designated extension state (EPC)
BA ME RS
DOCDB simple family (publication)
WO 2011023805 A1 20110303; EP 2480249 A1 20120801; EP 2480249 B1 20150128; ES 2534911 T3 20150430; US 2012189609 A1 20120726; US 2013330318 A1 20131212; US 8920794 B2 20141230
DOCDB simple family (application)
EP 2010062584 W 20100827; EP 10751599 A 20100827; ES 10751599 T 20100827; US 201013392623 A 20100827; US 201313968775 A 20130816